Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Development and characterization of pepducins as Gs-biased allosteric agonists.

Authors: Carr 3rd, Richard; Du, Yang; Quoyer, Julie; Panettieri Jr, Reynold A; Janz, Jay M; Bouvier, Michel; Kobilka, Brian K; Benovic, Jeffrey L

Published In J Biol Chem, (2014 Dec 26)

Abstract: The β2-adrenergic receptor (β2AR) is a prototypical G protein-coupled receptor that mediates many hormonal responses, including cardiovascular and pulmonary function. β-Agonists used to combat hypercontractility in airway smooth muscle stimulate β2AR-dependent cAMP production that ultimately promotes airway relaxation. Chronic stimulation of the β2AR by long acting β-agonists used in the treatment of asthma can promote attenuated responsiveness to agonists and an increased frequency of fatal asthmatic attacks. β2AR desensitization to β-agonists is primarily mediated by G protein-coupled receptor kinases and β-arrestins that attenuate receptor-Gs coupling and promote β2AR internalization and degradation. A biased agonist that can selectively stimulate Gs signaling without promoting receptor interaction with G protein-coupled receptor kinases and β-arrestins should serve as an advantageous asthma therapeutic. To identify such molecules, we screened ∼50 lipidated peptides derived from the intracellular loops of the β2AR, known as pepducins. This screen revealed two classes of Gs-biased pepducins, receptor-independent and receptor-dependent, as well as several β-arrestin-biased pepducins. The receptor-independent Gs-biased pepducins operate by directly stimulating G protein activation. In contrast, receptor-dependent Gs-biased pepducins appear to stabilize a Gs-biased conformation of the β2AR that couples to Gs but does not undergo G protein-coupled receptor kinase-mediated phosphorylation or β-arrestin-mediated internalization. Functional studies in primary human airway smooth muscle cells demonstrate that Gs-biased pepducins are not subject to conventional desensitization and thus may be good candidates for the development of next generation asthma therapeutics. Our study reports the first Gs-biased activator of the β2AR and provides valuable tools for the study of β2AR function.

PubMed ID: 25395624 Exiting the NIEHS site

MeSH Terms: Adrenergic beta-Agonists/pharmacology*; Allosteric Regulation; Amino Acid Sequence; Cyclic AMP/biosynthesis; GTP-Binding Protein alpha Subunits, Gs/metabolism*; HEK293 Cells; Humans; Molecular Sequence Data; Peptide Fragments/chemistry; Peptide Fragments/pharmacology*; Peptide Library; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Protein Structure, Tertiary; Protein Transport; Receptors, Adrenergic, beta-2/chemistry; Receptors, Adrenergic, beta-2/metabolism; Second Messenger Systems

to Top